Thus, in this review, it is intended to describe changes in PLC isozyme gene and protein expression as well as isozyme activities in cardiac hypertrophy due to different etiologies and in isolated cardiomyocytes in response to norepinephrine. Here, HSPG2 is linked to cardiac hypertrophy.